Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,763 total articles
Micron's exposure to AI-driven memory demand, improving cost-per-bit dynamics, and active capital allocation make it a compelling trade. This note lays out a concrete entry at $110.00, a stop at $95.00, and a primary target of $150.00 over a 180 trading day horizon, with scenario logic and risks.
TechnipFMC (FTI) has been a standout performer this year, but valuation and near-term technicals argue for taking profits. Market cap is roughly $30.5B with a P/E near 27 and EV/EBITDA of about 15.6. Given the recent run to a $80.70 52-week high and cooling momentum, we downgrade our rating and recommend a tactical short entry at $78.00 with a $82.…
Meta’s massive free cash flow, reasonable multiple and advertising moat make it the higher-probability trade in an AI-saturated market. For traders, a swing-long into AI enthusiasm with a disciplined stop captures upside from Muse and ad monetization while limiting risk from cyclicality and macro pressure. Reddit remains an asymmetric long-term ups…
Barings BDC (BBDC) is trading at roughly a 19% discount to book value despite an attractive yield, solid earnings, and a recent $350M bond issuance that eases short-term funding concerns. This trade idea recommends buying into weakness with a clear entry, stop and target on a 180-trading-day horizon.
Toast reported 23% revenue growth and record location adds in Q2, raised recurring gross profit and adjusted EBITDA guidance, and is trading at roughly 7.6x EV/ARR. The fundamentals argue the recovery narrative remains intact; this trade targets a move back toward the 52-week high while keeping a disciplined stop.
Agnico Eagle (AEM) combines low leverage, strong free cash flow and diversified mine assets. After a sharp move down from this summer's low to $134 and a rebound to the low $200s, AEM looks buyable at the $200 level for a mid-term swing (45 trading days) to $230, with a tight stop at $190 to protect capital against gold or operational shocks.
Broadcom's earnings machine is better understood as a software-enabled cash engine rather than a pure silicon play. Street concerns about margin degradation miss the company's ability to re-price, cut costs, and redeploy cash into buybacks and strategic tuck-ins. We outline a trade that captures upside while protecting against a near-term cyclical …
Zillow is trading at roughly $32 and a market cap near $7.3B despite generating $258M in free cash flow, a low debt load and clear advantages in listings data, consumer reach and AI-driven engagement. Short-term headline risk has compressed the multiple; we think the market is underestimating Zillow's moat. Trade idea: buy at $32.16, target $44.00,…
Viatris is generating meaningful free cash flow and is priced cheaply on cash-flow metrics. Operational savings, regulatory readouts and a specialty pipeline make a 180-day re-rating plausible. Trade plan provided with entry, stop and target tied to concrete catalysts and balance-sheet strength.
ASML's dominant position in EUV lithography, recent guidance on Low-NA shipments and reported capacity expansion plans across the industry create a favorable backdrop. While there is not a public Samsung order announcement in this dataset, regional capex flow and memory maker optimism imply added demand. Trade plan: enter $1725.00, target $1950.00,…
Pharvaris looks primed for meaningful upside after regulatory progress on its oral B2 receptor antagonist and strong prophylaxis data. With a market cap of roughly $2.66 billion, positive trial readthrough and manageable short interest create a favorable risk-reward. We rate PHVS a Strong Buy with a defined entry at $38.00, stop at $33.00 and a 180…
K92 Mining remains one of the higher-quality junior producers in the gold space thanks to high-grade underground production, near-term expansion optionality and meaningful exploration upside. That combination can justify trading at a premium to many peers. This trade idea recommends a tactical long with a strict stop and staged profit-taking tied t…
Vistra (VST) is a diversified power producer trading near $150 with a $50.6B market cap, strong free cash flow and direct exposure to AI data center electrification. Recent share-price weakness has priced in near-term operational/regulatory hiccups. We see a high-probability path to a guidance beat and multiple expansion as long-term power contract…
CVR Partners (UAN) combines a defensive, asset-backed business with an unusually high cash yield and attractive valuation. Recent global ammonia supply tightness originating in the Middle East has lifted fertilizer pricing and creates a favorable backdrop for UAN's cash distributions. With a market cap around $1.4B, P/E roughly 8.8x and EV/EBITDA n…
Structure Therapeutics has clinical data and cash runway that justify buying a mid-size position on weakness. Recent sector readouts have shifted near-term sentiment, but aleniglipron's 16%+ placebo-adjusted weight loss, low discontinuation and the company’s funding events keep upside intact. Trade plan: enter at $42.09, target $65.00, stop $30.00,…
Credo Technology has been punished despite 100%+ top-line growth and a pathway to $600M+ in optical revenue this year. The sell-off has left an expensive but still justifiable growth multiple for investors positioned for AI infrastructure adoption. We lay out an actionable long trade with entry, stop and staged targets tied to fundamental and techn…
ServiceNow has shrugged off the 'SaaSpocalypse' headlines: Q2 2026 AI annual contract value topped $1B and subscription revenue grew 24.5% to $3.88B. The shares trade at a premium, but strong free cash flow, expanding AI traction with big customers, and a durable platform moat justify a tactical long. This trade plan looks for a mid-term rebound in…
Phathom Pharmaceuticals is showing commercialization momentum for VOQUEZNA (vonoprazan): $58.3M of Q1 2026 revenue (+104% YoY) and 1.35M prescriptions to date. With a sub-$1B market cap, improving technicals and high short interest, a mid-term long trade can capture a re-rating if uptake continues and conference catalysts produce positive investor …
STMicroelectronics is positioned to convert top-line recovery into outsized operating leverage over the next 3-6 months. We outline three catalysts - automotive microcontroller demand, power/gate-driver traction, and structural margin tailwinds from mix and FCF generation - and present an actionable long trade with a clear entry, stop and target.
Rocket Lab (RKLB) trades like a growth story with no path to profit. The market is underestimating two things: (1) the near-term impact of the planned Iridium acquisition (adds $884M revenue at ~72% gross margins) and (2) recurring revenue from space systems and government contracts that are already winning work. Enter a tactical long with defined …
Brown-Forman (BF.B) is trading below paid-in equity multiples while generating steady free cash flow and a 3.5%+ yield. Recent headline volatility from takeover speculation has created a cleaner entry opportunity; the business itself supports a conservative, actionable long trade over the next 45 trading days.
Wd-40 Co. is a compact, highly profitable consumer-industrial franchised business that has shown recent top-line acceleration and margin expansion. With a market cap near $2.67B, a P/E around 30, and free cash flow of roughly $79.5M, the stock looks expensive but not overpriced given its cash generation, capital returns and pronounced brand moat. W…
A jury award of $604 million has rattled C.H. Robinson (CHRW) shares, but the company’s underlying cash generation, conservative liquidity ratios, and attractive technical setup argue for a tactical long. This trade targets a near-term rebound to $170 with a longer target into $195 if legal risks settle or are reduced on appeal.
PayPal is trading beneath $55 after rejecting a $60.50 takeover offer. The company is unambiguously cheaper than peers on several metrics and still prints strong cash flow, but earnings multiple will only re-rate if execution on Venmo, branded checkout and BNPL shows durable margin improvement. This trade idea targets a re-rating to roughly 12x ear…
Blue Moon Metals (BMM) is executing a playbook that reduces typical junior-miner execution risk: secured processing access via Teck, a strategic capital top-up from Hartree, and a 35,000-45,000m 2026 drill program across multiple critical-metal assets. At a market cap near $497M and current trading around $5.89, the stock offers a favorable risk/re…
